Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis

Defining the molecular pathology of pancreatic body and tail adenocarcinoma

(2018) S. B. Dreyer et al.   BRITISH JOURNAL OF SURGERY

Underestimation of pancreatic cancer in the national cancer registry – Reconsidering the incidence and survival rates

(2017) J. Fest et al.   EUROPEAN JOURNAL OF CANCER

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

(2017) John P Neoptolemos et al.   LANCET

Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands

(2016) N. Haj Mohammad et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial

(2016) Eva Versteijne et al.   Trials

Volume–outcome relationships in pancreatoduodenectomy for cancer

(2016) Lydia G.M. van der Geest et al.   HPB

The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis

(2016) Maikel J. Bakens et al.   Cancer Medicine

Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands

(2015) Lydia G. M. van der Geest et al.   ACTA ONCOLOGICA

Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5

(2015) Côme Lepage et al.   EUROPEAN JOURNAL OF CANCER

Describing Patterns of Care in Pancreatic Cancer

(2015) Elizabeth A. Burmeister et al.   PANCREAS

The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma

(2015) Dietrich A. Ruess et al.   BMC Surgery

Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer

(2013) Ryan P. Merkow et al.   ANNALS OF SURGERY

Uptake and Patterns of Use of Gemcitabine for Metastatic Pancreatic Cancer: A Population-Based Study

(2013) Paul E. Oberstein et al.   CANCER INVESTIGATION

Biliary stenting: Indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline

(2012) J.-M. Dumonceau et al.   ENDOSCOPY

Pancreatic Adenocarcinoma: Complete Tumor Extirpation Improves Survival Benefit Despite Larger Tumors for Patients Who Undergo Distal Pancreatectomy and Splenectomy

(2011) Paul Toomey et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant Therapy

(2011) Skye C. Mayo et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preoperative Biliary Drainage for Cancer of the Head of the Pancreas

(2010) Niels A. van der Gaag et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence and Survival of Pancreatic Head and Body and Tail Cancers

(2010) Melvin K. Lau et al.   PANCREAS

Management and prognosis of pancreatic cancer over a 30-year period

(2009) M David et al.   BRITISH JOURNAL OF CANCER

Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland

(2009) L. Sharp et al.   EUROPEAN JOURNAL OF CANCER